Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> : a pooled analysis of Phase 3 clinical trials - Concepedia

Concepedia

Publication | Open Access

Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> : a pooled analysis of Phase 3 clinical trials

DOI Full Paper Access

115

Citations

12

References

2016

Year

Myra W. Popejoy, David L. Paterson, Daniel Cloutier, Jennifer A. Huntington, Benjamin Miller, Caleb Bliss, Judith N. Steenbergen, Ellie Hershberger, Obiamiwe Umeh, Keith S. Kaye

Journal of Antimicrobial Chemotherapy

Abstract

Randomized trial data demonstrated high clinical cure rates with ceftolozane/tazobactam treatment of cIAI and cUTI caused by ESBL-ENT.

References

	Year	Citations

Page 1